PATIENT INFORMATION LEAFLET

Similar documents
PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET

PATIENT INFORMATION LEAFLET. Calcichew* 500 mg Chewable Tablets calcium carbonate

Package leaflet: Information for the user. Calcichew-D 3 Citron 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )

Package leaflet: Information for the user. Calcichew-D 3 Melon 500 mg/1000 IU chewable tablets calcium/cholecalciferol (vitamin D 3 )

Package leaflet: Information for the use. Calcichew-D3 Citron 500 mg/400 IU chewable tablets calcium / cholecalciferol (vitamin D3)

Package leaflet: Information for the user

Package leaflet: Information for the user. Calcichew-D 3 Forte Double Strength 1000 mg/800 IU chewable tablets calcium/colecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER. <PRODUCT NAME> 600 mg / 1,000 IU orodispersible tablets. Calcium/cholecalciferol (Vitamin D3)

Package leaflet: Information for the user. Calciflex-D 3 Citron 500 mg/400 IU film-coated tablets calcium/cholecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER RENNIE DUAL ACTION TABLETS. Calcium carbonate, Magnesium carbonate, Alginic acid Chewable tablets

Package leaflet: Information for the user. Recikalc-D forte 500 mg/800 IU chewable tablets. Calcium/cholecalciferol (Vitamin D3)

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the user. Kalcipos-D forte 500 mg/800 IU film-coated tablets. Calcium/cholecalciferol (Vitamin D3)

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

SUMMARY OF THE PRODUCT CHARACTERISTICS

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Package leaflet: Information for the user. Calcichew-D 3 Citron 1000 mg/800 IU chewable tablets calcium/cholecalciferol (vitamin D 3)

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Fultium can also be used as an adjunct to specific bone loss medication

Excipient(s) with known effect: One tablet contains 1 mg aspartame (E951), 390 mg sorbitol (E420) and 0.7 mg sucrose

Sibelium 5 mg Tablets flunarizine

2. What you need to know before you take DDAVP/Desmopressin Tablets

Package leaflet: Information for the user. Burinex 5 mg Tablets bumetanide

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate

SUMMARY OF PRODUCT CHARACTERISTICS. One chewable tablet contains 1250 mg calcium carbonate (equivalent to 500 mg calcium).

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. altavitad3 25,000 IU oral solution colecalciferol

Summary of Product Characteristics

Article 30 Referral for Calcitugg (and associated names) Chewable tablets (Calcium carbonate)

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT

Package leaflet: Information for the patient. Torarese 2.5 mg tablets Torarese 5 mg tablets Torarese 10 mg tablets Torarese 20 mg tablets.

PACKAGE LEAFLET: INFORMATION FOR THE USER ZIRPINE 10mg TABLETS Cetirizine dihydrochloride

Dosage in renal impairment Kalcipos-D chewable tablets should not be used in patients with severe renal impairment.

Package leaflet: Information for the user. Lycimor 300 mg Hard Capsules Lymecycline (equivalent to 300mg of tetracycline base)

Package leaflet: Information for the patient

1. NAME OF THE MEDICINAL PRODUCT. Calciflex-D 3 Citron 500 mg/400 IU film-coated tablets 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Package leaflet: Information for the patient. SIRTURO 100 mg tablets Bedaquiline

SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

1. What Octostim Nasal Spray is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Finasteride 5mg Film-coated Tablets. (Finasteride) This medicine is for use in men only

1. What Betahistine dihydrochloride tablets is and what it is used for

THORENS I.U. /ml oral drops, solution Cholecalciferol (vitamin D 3 )

PACKAGE LEAFLET: INFORMATION FOR THE USER. EASOFEN MAX STRENGTH 400mg FILM-COATED TABLETS. Ibuprofen

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

SUMMARY OF THE PRODUCT CHARACTERISTICS

PACKAGE LEAFLET: INFORMATION FOR THE USER. ZADITEN 1 mg/5 ml Oral Solution. Ketotifen (as Ketotifen hydrogen fumarate)

PYRIDOSTIGMINE LIME TM 60MG TABLETS Pyridostigmine bromide

Package leaflet: Information for the user. Resolor 1 mg film-coated tablets Resolor 2 mg film-coated tablets prucalopride

PACKAGE LEAFLET: INFORMATION FOR THE USER. Dantrium 25 mg Capsules / Dantrium 100 mg Capsules Dantrolene sodium

Sanomigran 500 microgram Tablets and Sanomigran 1.5 mg Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER. Raloxifen STADA 60 mg film-coated tablets (raloxifene hydrochloride)

Package leaflet: Information for the patient. Velphoro 500 mg chewable tablets Iron as sucroferric oxyhydroxide

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER. DF118 Tablets 30mg (Dihydrocodeine Hydrogen Tartrate)

SUMMARY OF THE PRODUCT CHARACTERISTICS

Package leaflet: Information for the patient. Risedronate sodium 35 mg film-coated tablets. Risedronate sodium

Package leaflet: Information for the patient. Selincro 18 mg film-coated tablets nalmefene

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Pyrazinamide 500 mg Tablets (Macleods Pharmaceuticals Ltd), TB243. WHOPAR part 3 April 2014 Section 6 updated: May 2014 PACKAGE LEAFLET.

Ascorbic Acid. Dr. Scheffler Vitamin C effervescent tablets are used for the treatment of vitamin C deficiency diseases (e. g. scurvy).

Atrosan Devil s Claw film-coated tablets

Package leaflet: Information for the user. Raxone 150 mg film-coated tablets idebenone

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

Package Leaflet: Information for the User

PACKAGE LEAFLET: INFORMATION FOR THE USER Paracodin 0.20% w/w Syrup (dihydrocodeine hydrogen tartrate)

Package leaflet: Information for the user. Zomig 2.5 mg tablets zolmitriptan

Package leaflet: Information for the user Zirtek Allergy Relief 10 mg film-coated tablets Cetirizine dihydrochloride

1. What Solpadol is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. Venaforce Varicose Veins gastro-resistant tablets Horse Chestnut seed dry extract

Package leaflet: Information for the patient. Flynise 5 mg Orodispersible Tablets desloratadine

Pravat 40 mg tablets. Pravastatin sodium

Zofran tablets contain a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Maxilief Effervescent Tablets

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

Package leaflet: Information for the user. Salofalk 3g gastro-resistant prolonged-release granules. Mesalazine

Irbenida H 150mg/12,5mg film-coated tablets

Dulcolax 5 mg, film-coated tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER Insomniger 10mg and 20mg Tablets (temazepam)

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Package leaflet: Information for the user. Omnilax 10 g powder for oral solution, sachet. Macrogol 4000

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

Package Leaflet: Information for the user. Anti-Hist Allergy 10mg Film-Coated Tablets. Cetirizine dihydrochloride

Package leaflet: Information for user

PACKAGE LEAFLET: INFORMATION FOR THE USER. Alendronic Acid 10 mg Tablets

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

Zofran syrup contains a medicine called ondansetron. This belongs to a group of medicines called anti-emetics.

Package leaflet: Information for the patient

PACKAGE LEAFLET: INFORMATION FOR THE USER

Transcription:

PATIENT INFORMATION LEAFLET CALCICHEW*-D 3 FORTE CHEWABLE TABLETS calcium carbonate / colecalciferol equivalent to 500mg Calcium / 400IU colecalciferol Read all of this leaflet carefully because it contains important information for you. This medicine is available without prescription. However, you still need to take Calcichew-D 3 Forte Chewable Tablets carefully to get the best results from it. - Keep this leaflet. You may need to read it again. - Ask your pharmacist if you need more information or advice. - You must contact a doctor if your symptoms worsen or do not improve after two weeks. - If any of these side-effects become serious, or if you notice any side effects not listed in this leaflet, please talk to your doctor or pharmacist. In this leaflet: 1. What Calcichew-D 3 Forte Tablets are and what they are used for 2. Before you take Calcichew- D 3 Forte 3. How to take Calcichew- D 3 Forte 4. Possible side effects 5. How to store Calcichew- D 3 Forte 6. Further information 1. WHAT CALCICHEW- D 3 FORTE ARE AND WHAT THEY ARE USED FOR Calcichew- D 3 Forte are lemon flavoured chewable tablets. They contain the active ingredients: Calcium (1250mg calcium carbonate: equivalent to 500mg calcium) vitamin D 3 (400IU colecalciferol: equivalent to 10 micrograms vitamin D 3 ) Both calcium and vitamin D are found in the diet and vitamin D is also produced in the skin after exposure to the sun. Calcichew- D 3 Forte Chewable Tablets may be prescribed by doctors or recommended by pharmacists to treat and prevent vitamin D/calcium deficiency, or when the diet or lifestyle does not provide enough, or when body requirements are increased. This medicine may also be prescribed or recommended for certain bone conditions, for example osteoporosis, or in pregnancy. 2. BEFORE YOU TAKE CALCICHEW- D 3 FORTE Do not take Calcichew- D 3 Forte if you: are allergic (hypersensitive) to any of the ingredients (see end of Section 2 and Section 6) have a condition causing high levels of calcium in your blood or urine (hypercalcaemia or hypercalciuria) e.g. o renal (kidney failure) o cancer that has affected your bones

have high levels of vitamin D in your blood have kidney stones. Take special care with Calcichew- D 3 Forte : If any of the following applies to you, please tell your doctor: phenylketonuria (a deficiency in the enzyme which breaks down phenylalanine) as these tablets contain aspartame, a source of phenylalanine brittle bones (osteoporosis) as a result of being immobile taking medicines for your heart, or diuretics a high tendency to kidney stone (calculus) formation cancer or any other condtions that may have affected your bones. If you have any of the following conditions your serum calcium or phosphate levels, or urinary calcium excretion must be monitored. Calcichew should be taken under close medical supervision. sarcoidosis (an immune system disorder which may affect your liver, lungs, skin or lymph nodes) kidney problems you are on long-term treatment with Calcichew you are already taking additional doses of calcium or vitamin D. If you have increased calcium levels in the blood or develop signs of kidney problems, the dose of Calcichew-D 3 Forte should be reduced or the treatment discontinued. Taking other medicines Please inform your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. In particular, the following medicines may interact with Calcichew-D 3 Forte tablets: diuretics (water tablets); your serum calcium levels should be monitored regularly. heart medicines (cardiac glycosides); you should be monitored by electrocardiogram and your serum calcium levels measured. corticosteroids (e.g. prednisolone, dexamethasone); your dose of Calcichew- D 3 Forte may need to be increased laxatives (such as paraffin oil) or a cholesterol-lowering drug called colestyramine. tetracycline antibiotics; these should be taken at least two hours before, or four to six hours afterwards. hormones (levothyroxine); these should be taken at least four hours before, or afterwards. anti-infectives (Quinolones: Ciprofloxacin, lomefloxacin, norfloxacin, sparfloxacin): please speak with your doctor. fluoride, or bisphosphonates; Calcichew- D 3 Forte should be taken at least three hours afterwards. Calcium salts may decrease the absorption of iron, zinc and strontium ranelate. Consequently iron, zinc or strontium ranelate preparations should be taken at least two hours before or after Calcichew- D 3 Forte. Orlistat (used to treat obesity) may disturb the absorption of fat-soluble vitamins, e.g. vitamin D3.

Taking Calcichew- D 3 Forte with food and drink Calcichew- D 3 Forte should not be taken within 2 hours of eating foods rich in oxalic acid (found in spinach and rhubarb) or phytic acid (found in whole cereals). Pregnancy and breastfeeding Ask your doctor or pharmacist for advice if you are pregnant or breast-feeding before taking Calcichew- D 3 Forte. Driving and using machines Calcichew- D 3 Forte has no known effect on your ability to drive or use machines. Important information about some of the ingredients of Calcichew- D 3 Forte The following are ingredients in this product: Sorbitol, isomalt and sucrose: if you have been told by your doctor that you have an intolerance to some sugars, talk to your doctor before taking this medicine. May be harmful to teeth. Aspartame contains a source of phenylalanine and may be harmful to people with phenylketonuria (a deficiency in the enzyme which breaks down phenylalanine). 3. HOW TO TAKE CALCICHEW- D 3 FORTE Always take Calcichew- D 3 Forte Tablets exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Adults and elderly: Chew or suck the two tablets a day, preferably one tablet in the morning and one in the evening. Children: Calcichew- D 3 Forte Tablets are not recommended for use in children If you take more than you should If you accidentally take more Calcichew- D 3 Forte Chewable Tablets than you should, you may have an increase in your blood calcium levels. Symptoms of this are: excessive thirst, nausea, vomiting, constipation, abdominal pain, muscle weakness, tiredness, mental disturbances, lack of appetite, bone pain, having to pass more water than usual, kidney problems and, in severe cases, irregular heartbeat. Very rarely in addition: irritability, continuing headache, lightheadedness, muscle spasms, twitches and tingling sensation. Do not take any more Calcichew-D3 Forte and contact your doctor or emergency department as soon as possible. Take the packet and any remaining tablets with you. If you forget to take Calcichew- D 3 Forte If you forget to take a dose, leave out that dose completely. Take your next dose when it is due. Do not take a double dose to make up for a forgotten dose.

4. POSSIBLE SIDE-EFFECTS Like all medicines, Calcichew- D 3 Forte can cause side-effects, although not everybody gets them. Side effects with Calcichew- D 3 Forte may include: Uncommon side-effects (affecting less than 1 in 100 people): too much calcium in your blood (hypercalcaemia) the symptoms include nausea, vomiting, lack of appetite, constipation, stomach ache, bone pain, extreme thirst, a need to pass more water than usual, muscle weakness, drowsiness and confusion. too much calcium in your urine (hypercalciuria) Rare side-effects (affecting less than 1 in 1000 people): nausea stomach ache constipation diarrhoea wind (flatulence) rash hives itching Very rare side-effects (affecting less than 1 in 10000 people): Milk alkali syndrome (usually only seen in overdose see if you take more than you should ) Frequency not known (cannot be estimated from the available data): Hypersensitivity reactions such as swelling of the face, tongue, lips (angioedema) or swelling of the throat (laryngeal oedema). If you have impaired renal function, you may be at risk of increased amounts of phoshate in the blood, renal stone formation and increased amounts of calcium in the kidneys. Reporting of side effects If you get any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517. Website:www.hpra.ie; E-mail: medsafety@hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. 5. HOW TO STORE CALCICHEW-D 3 FORTE Keep out of the reach and sight of children. Store in the original package. Keep container tightly closed to protect from moisture. Do not store above 30 C Do not use Calcichew- D 3 Forte Tablets after the expiry date which is stated on the label after EXP. The expiry date refers to the last date of that month. If the tablets have changed shape or colour do not use.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. FURTHER INFORMATION What Calcichew-D 3 Forte Chewable Tablets contain The active ingredients in each tablet are: 1250mg calcium carbonate (equivalent to 500mg calcium) 400IU colecalciferol (equivalent to 10 micrograms vitamin D 3 ) The other ingredients are: sorbitol (E420), povidone, isomalt (E953), fatty acid mono- and diglycerides, magnesium stearate, lemon flavour, aspartame (E951), sucrose, tocopherol, modified maize starch, medium-chain triglycerides, sodium ascorbate and anhydrous colloidal silica, (see also end of Section 2 Important information about some of the ingredients of Calcichew- D 3 Forte Chewable Tablets ). What Calcichew-D 3 Forte look like and contents of the pack The tablets are round, white, uncoated, convex and lemon flavoured; they may have small specks. The tablets are packed in white, plastic bottles of 60 and 100 tablets. Not all pack sizes may be marketed. Marketing Authorisation Holder Takeda UK Ltd., Building 3, Glory Park, Glory Park Avenue, Wooburn Green, BUCKS, HP10 0DF, United Kingdom Manufacturer Takeda Nycomed AS, Drammensveien 852, N-1385 Asker, Norway. This leaflet was last revised in December 2014. Additional Information Calcichew-D 3 Forte are a combination of calcium and vitamin D designed to keep bones healthy. Calcium is an essential component of bones while vitamin D plays an important role in the absorption of calcium from food. Requirements for calcium increase with age and, although many people obtain enough calcium from their diet, some people may require a supplement in order that their body has all the calcium it needs to maintain healthy bones. Vitamin D is produced largely from the action of sunlight. Certain foodstuffs do contain vitamin D in reasonable amounts but it is not always possible to obtain all the vitamin D you need from your diet. People who do not get out and about, for instance those who are housebound or people living in nursing and residential homes, may not receive all the vitamin D they need. People with diets and lifestyles that mean they will obtain less than the recommended intake of calcium and vitamin D are at risk of weakened bones. Prolonged lack of adequate calcium and vitamin D intake can lead to the development of osteoporosis, a condition where bones become weak to a level that minimal trauma (for example, a fall) can result in a fracture, most typically at the hip, spine or wrist.

Calcichew-D 3 Forte have been designed to give people whose intakes of calcium and vitamin D are low a boost to the recommended amounts. Maintaining healthy bones and helping to avoid osteoporosis is an important issue for many people. There are many ways that people can help themselves: regular exercise, a balanced diet with an adequate intake of calcium and vitamin D and, for some people, advice on how to prevent falls which may lead to fracture. The National Osteoporosis Society (NOS) in the UK and the Irish Osteoporosis Society (IOS) in the Republic of Ireland, are national charities dedicated to improving the diagnosis, prevention and treatment of osteoporosis. The NOS and IOS offer support to people with osteoporosis and raise awareness of the importance of healthy bones. For patients in the UK, if you are concerned about osteoporosis, please contact the National Osteoporosis Society, Camerton, Bath BA2 0PJ. Tel: 01761 471 771, Fax: 01761 471 104 or email: info@nos.org.uk. For patients in the Republic of Ireland, please contact the Irish Osteoporosis Society, 114 Pembroke Road, Garden Level, Ballsbridge, Dublin 4. Tel: 1890 252 751, Fax: +353 (0)1 668 0098, email: info@irishosteoporosis.ie. *Registered Trademark